Specialty Sales Representative – Cardiometabolic Rare Disease

Scorpion Therapeutics; Omaha (NE); On-site; USD 110,000 - 170,000; Full time

Job summary

Scorpion Therapeutics in Omaha, NE is seeking a Specialty Sales Representative to launch and expand Arrowhead's cardiometabolic RNAi therapies, including Plozasiran for rare cardiovascular conditions.

You will develop data-driven territory plans, educate clinicians through clinical engagement, and build relationships with healthcare providers while navigating complex healthcare systems and partnering with marketing, medical, and access teams.

Qualifications

• 5+ years of pharma sales experience.
• 3+ years in specialty, rare disease, or cardiovascular areas.
• Proven success launching complex therapies.
• Experience with IDNs is preferred.

Responsibilities

• Develop data-driven territory plans and achieve sales targets.
• Conduct clinical education for healthcare providers.
• Build relationships with healthcare providers and navigate healthcare systems.
• Collaborate cross-functionally with marketing, medical, and access teams.

Skills

Pharma sales

Specialty/rare disease experience

Cardiovascular knowledge

Clinical education

Cross-functional collaboration

Education

Bachelor's degree or equivalent

Job description

Role

Specialty Sales Representative focused on launching and expanding Arrowhead's cardiometabolic RNAi therapies, including Plozasiran for rare cardiovascular conditions such as FCS and SHTG.

Responsibilities

develop data-driven territory plans, achieve sales targets, conduct clinical education, build relationships with healthcare providers, navigate complex healthcare systems, and collaborate cross-functionally with marketing, medical, and access teams.

Requirements

Bachelor's degree or equivalent, minimum 5 years of pharma sales experience, with 3+ years in specialty, rare disease, or cardiovascular areas; success in launching complex therapies; experience with IDNs preferred.

HighValue

specialty pharma, cardiometabolic indications, rare disease, RNAi therapeutics, complex healthcare system navigation, clinical engagement, and cross-functional collaboration.

WorkSetup

field-based with approximately 30% travel, including regional and national meetings.